ABSTRACT After adrenalectomy, the plasma levels of adrenocorticotropic hormone (corticotropin, ACTH)/endorphin peptides in rats rise dramatically in the first 4 hr while pituitary peptide levels fall sharply. Eight hours after adrenalectomy, plasma levels are near control values again but they then increase continuously over the next 8 days. Proopiomelanocortin (POMC) mRNA levels in the anterior pituitary (quantitated by hybridization with cloned POMC cDNA) increase 2-fold in the first 24 hours, reaching 15-to 20-fold the control level 18 days after adrenalectomy. When dexamethasone is administered to rats 8 days after adrenalectomy, the above events are reversed. Plasma ACTH falls to control levels within 2 hr whereas anterior pituitary POMC mRNA requires 5 days of treatment for return to control levels. The levels of POMC mRNA in the neurointermediate lobe and the hy- The gene(s) encoding proopiomelanocortin (POMC) in the mammalian neuroendocrine system is under complex hormonal control and is expressed in a tissue-specific manner (1-4). In the corticotrophic cells of the anterior pituitary, POMC is proteolytically processed to adrenocorticotropic hormone (corticotropin, ACTH), &3lipotropin, and amino-terminal peptide and secreted (5, 6). Secretion in these cells is thought to be negatively regulated by serum glucocorticoids and under positive control by hypothalamic corticotropin-releasing factor (CRF) (2, 7, 8) .
ABSTRACT After adrenalectomy, the plasma levels of adrenocorticotropic hormone (corticotropin, ACTH)/endorphin peptides in rats rise dramatically in the first 4 hr while pituitary peptide levels fall sharply. Eight hours after adrenalectomy, plasma levels are near control values again but they then increase continuously over the next 8 days. Proopiomelanocortin (POMC) mRNA levels in the anterior pituitary (quantitated by hybridization with cloned POMC cDNA) increase 2-fold in the first 24 hours, reaching 15-to 20-fold the control level 18 days after adrenalectomy. When dexamethasone is administered to rats 8 days after adrenalectomy, the above events are reversed. Plasma ACTH falls to control levels within 2 hr whereas anterior pituitary POMC mRNA requires 5 days of treatment for return to control levels. The levels of POMC mRNA in the neurointermediate lobe and the hypothalamus are not altered by either treatment. Adrenalectomy increases transcription of the POMC gene in the anterior pituitary approximately 20-fold and halves transcription of the growth hormone gene within 1 hr of operation. Administration of dexamethasone immediately after adrenalectomy suppresses the increase in transcription of the POMC gene and increases the transcription of the growth hormone gene. Transcription of the POMC gene(s) in the neurointermediate lobe is not altered by either of these treatments.
The gene(s) encoding proopiomelanocortin (POMC) in the mammalian neuroendocrine system is under complex hormonal control and is expressed in a tissue-specific manner (1-4). In the corticotrophic cells of the anterior pituitary, POMC is proteolytically processed to adrenocorticotropic hormone (corticotropin, ACTH), &3lipotropin, and amino-terminal peptide and secreted (5, 6) . Secretion in these cells is thought to be negatively regulated by serum glucocorticoids and under positive control by hypothalamic corticotropin-releasing factor (CRF) (2, 7, 8) .
The POMC gene(s) is also expressed in the neurointermediate lobe of the pituitary (9, 10) and hypothalamus (9) . In the neurointermediate lobe, the POMC gene is expressed in virtually every cell and is thought to be under negative regulation via dopaminergic neurons descending from the hypothalamus (11) . The primary secretion products from the neurointermediate lobe are a-melanocyte-stimulating hormone (a-MSH), corticotropin-like intermediate lobe peptide and (3-endorphin (12) . In the hypothalamus, POMC mRNA was also detected but at very low levels (9) . In addition, a protein of the approximate size of POMC is synthesized in hypothalamic cultures and it has been shown to crossreact with ACTH and -endorphin antibodies (13) .
One can study the effect of glucocorticoids on POMC gene expression in intact animals by removing the tissue that produces these steroids, the adrenal cortex. When this is done, the ACTH level in the blood rises dramatically within a few minutes and then falls, only to rise again several hours later (14) . In addition, Nakanishi et al. (15) have reported that POMC mRNA activity in total rat pituitary increases 2.5-fold after adrenalectomy. More recently, Schachter et al. (16) reported a 6.5-fold increase in anterior pituitary POMC mRNA levels 14 days after adrenalectomy. In this study, we have asked whether changes in blood levels of POMC peptides after adrenalectomy can be related to alterations in activity of the POMC gene(s) in the pituitary and hypothalamus as a result of adrenalectomy and glucocorticoid treatments.
We have measured gene expression by quantifying POMC gene transcription rates and the levels of POMC m,,RNA after adrenalectomy and subsequent glucocorticoid administration. To test for the possibility that POMC gene expression is regulated at the level of secretion, we have assayed the serum and anterior pituitaries from the same groups of animals for ACTH and P-endorphin peptide levels.
MATERIALS AND METHODS
Adrenalectomy and Dexamethasone Treatment. Six-weekold male Sprague-Dawley rats (University of Oregon strain derived from Charles River C/D strain) were used. Bilateral adrenalectomies and sham operations were carried out after administration of pentobarbital. During surgery, the sham-operated animals had their adrenals retracted and exposed but not excised. All animals were maintained on 0.9% saline after surgery. Dexamethasone (100 ttg) or vehicle was injected into the pericardium in sterile saline. Animals subjected to long-term dexamethasone treatment were given twice daily subcutaneous injections of 80 ug. Animals were sacrificed by decapitation.
The anterior lobe and neurointermediate/posterior lobe of the pituitary and hypothalami were dissected and immediately extracted or frozen in liquid nitrogen.
Corticosterone levels were determined by radioimmunoassay. Control and sham-operated rats had corticosterone at 20-50 pg/ml in their serum. In adrenalectomized rats, the corticosterone levels were below the level of detectability (5 (18) . The preparation of the single-stranded cDNA probe and the solution hybridization procedure were as described (9, 19) except that we used cytoplasmic RNA isolated from AtT20-D16v cells for which the POMC mRNA level had been previously determined as our hybridization standard.
POMC and Growth Hormone Transcription Rate Determinations. Nuclei were prepared from the anterior and neurointermediate/posterior lobes of groups of eight animals at 1 and 4 hr after adrenalectomy and dexamethasone treatment and incubated with 300 puCi each of [a-32P]UTP, -CTP, and -GTP (New England Nuclear) as described (20) . Nuclear RNA was isolated (21) and hybridized to nitrocellulose filter discs (20) on which 2 ttg of pBR322, pGHL (22) , an 800-base-pair rat growth hormone cDNA clone, or pMKSU16, a 923-base-pair mouse POMC cDNA clone (23), had been denatured and bound. After the hybridization, nonspecific radioactivity was removed by washing and RNase treatment (20) and the radioactivity on the filters was determined in a liquid scintillation counter. Specific transcription was calculated as the difference between radioactivity bound to control filters containing pBR322 and pMKSU16-or pGHl-containing filters in the same hybridization reaction. Results are expressed as cpm in the specific hybrid per 106 cpm in the hybridization mixture (ppm). Using RNA copies of plasmid clones (cRNA), we found hybridization efficiences of 35-45% (data not shown). Of concern to us was the use of a mouse POMC cDNA clone to probe for the rat POMC transcript. Comparison of the pMKSU16 cDNA clone (23) with the corresponding sequence of the main exon of the rat POMC gene (24) indicates that there is >92% sequence homology between the two genes.
ACTH Determinations in Serum and Anterior Pituitaries.
The ACTH antiserum used in the radioimmunoassays (14) is specific for the NH2-terminal region of ACTH1_39 as it crossreacts fully with ACTH1A24. It does not crossreact with a-MSH, the COOH-terminal portion of ACTH (ACTH24-39), 1endor-phin, 3-lipotropin, or ,B3MSH. The specificity of the ,B3endor-phin antiserum is described in ref. 6 . Acetic acid-soluble proteins were extracted from anterior pituitary lobes, lyophilized, suspended in buffer, and assayed for total protein and ACTH content (5) . RESULTS When the adrenal cortex is removed, there is a rapid rise in plasma levels of ACTH followed by a fall and then another rise. Concomitant with the rise in plasma ACTH, there is a fall in the anterior pituitary level of the peptide followed by a gradual rise (14) . In (Fig. 1A) , reaching 15 times that of the control level after 18 days. To determine whether the increase in POMC mRNA levels after adrenalectomy is due to removal of the endogenous source of glucocorticoids from the animals, some rats were treated with the synthetic glucocorticoid dexamethasone starting at day 8 after adrenalectomy. Animals were treated daily for up to 8 days and a time course of the POMC mRNA deinduction in the anterior pituitary was determined. As shown in The POMC mRNA level in the anterior lobes of sham-operated animals was essentially the same as in unoperated (Fig.  1A ) and 8-day dexamethasone-treated ( Fig. 1B) animals. When unoperated animals were treated with dexamethasone for 8 days, the POMC mRNA levels were found to be 20% of control levels (data not shown). These results suggest that POMC gene expression in normal male rats is in a partially repressed state maintained by endogenous glucocorticoids.
Effect of Adrenalectomy on POMC mRNA in the Neurointermediate Lobe and Hypothalamus. POMC expression in the neurointermediate lobe is under negative regulation by dopaminergic compounds and y-aminobutyric acid (11, 25) . Even less is known about regulation of POMC in the hypothalamus.
To test the effects of glucocorticoids on POMC gene expression in the neurointermediate lobe, lobes were removed from unoperated rats, from rats that had been sacrificed 8 days after adrenalectomy, and from rats that had been sacrificed 16 days after adrenalectomy with dexamethasone (20 ug/ml) in their water for the last 8 days. TNA was extracted from individual neurointermediate lobes to determine POMC mRNA levels. As shown in Fig. 2 , there were no major differences in POMC mRNA levels among the different groups of rats. A greater variation was detected in the POMC mRNA levels of neurointermediate lobes of animals within an experimental group than was generally observed in the anterior lobe (Fig. 2) . This may be due in part to the removal of some anterior lobe tissue along with the neurointermediate/posterior lobe tissue during some of the dissections.
To test the effects of eliminating serum glucocorticoids on POMC gene expression in the hypothalamus, it was necessary to pool the tissue from five hypothalami per point to have enough RNA to measure POMC mRNA levels accurately. RNA was purified as described in ref. 1 Hypothalami from five individuals were pooled to obtain sufficient RNA to accurately measure POMC mRNA levels. Hypothalami were removed from five rats that had been adrenalectomized 14 days earlier (bar 1) and from five control rats (bar C). Total RNA was prepared from hypothalami by homogenization in guanidinium thiocyanate followed by centrifugation over a CsCl pad (17) and assayed for POMC mRNA content by cDNA solution hybridization. sacrificed 14 days after adrenalectomy and assayed for POMC mRNA levels (Fig. 2) (21) .
The rate of POMC transcription increases by as much as 20-fold within 1 hr of adrenalectomy (Fig. 3A) . The same elevated level of POMC transcription was observed 4 hr after adrenalectomy. The observed increase in POMC transcription was completely suppressed by treatment of the animals with dexamethasone immediately after surgery. The POMC transcription rate in the animals sacrificed 1 hr after sham operation is below the limits of detectability (0.2-0.5 ppm). (1983) 6985 The assay of transcription rates 4 hr after adrenalectomy (Fig.  3B) showed that, in the neurointermediate lobe (i) transcription rate is approximately two orders of magnitude above that in the anterior lobe and (ii) there is no apparent effect on the POMC transcription rate under conditions that resulted in a marked increase in the anterior lobe after adrenalectomy.
The assay of the growth hormone transcription rate in the anterior lobe (Fig. 3C) showed that this rate is halved after adrenalectomy and is slightly increased after dexamethasone administration. Hence, the response of the growth hormone gene to adrenalectomy follows the predicted course and provides an independent check of the effectiveness of the surgery and the assay methodology. Although the growth hormone transcription rates do not vary over as large a range as the POMC rates, the assayed changes in growth hormone transcription are qualitatively what one would expect for a glucocorticoid-inducible gene in vivo.
Correlation of POMC Gene Expression with Pituitary and Serum ACTH Levels. An important aspect of this study was to correlate the temporal relationships of several parameters involved in the expression of a peptide hormone gene. Using POMC gene expression in the anterior pituitary as an example, we determined ACTH and 8-endorphin levels in the plasma and anterior pituitary by radioimmunoassay and POMC mRNA levels by solution hybridization in animals subjected to adrenalectomy followed by dexamethasone treatment. The results are plotted in Fig. 4 as percentage of control values.
Within 2 hr after adrenalectomy, the plasma ACTH levels increased six-fold with a concomitant drop in pituitary ACTH (Fig. 4A) . The levels of (3-endorphin immunoreactivity changed in essentially a parallel fashion to ACTH (data not shown). This is consistent with a rapid increase in ACTH and endcorphin release from the anterior pituitary following adrenalectomy, leading to a depletion of intracellular ACTH. By 24 hr after adrenalectomy, when the anterior pituitary POMC mRNA level had already increased >2-fold, a second increase in plasma ACTH was observed. There was then a more gradual rise in serum ACTH levels, roughly the same rate as POMC mRNA accu- Correlation of anterior pituitary POMC mRNA levels with plasma and pituitary ACTH levels after adrenalectomy (A) and subsequent dexamethasone treatment (B) . Levels of ACTH in aliquots of serum (A) from groups of five animals were determined by radioimmunoassay (14) . Acetic acid-soluble protein from the anterior pituitaries (o) of two or three individuals was extracted in the presence of protease inhibitors (5) and ACTH levels were determined by radioimmunoassay (5) . POMC mRNA levels (e) are replotted from the data in Fig. 1 Because this experimental system involves the removal of a negative regulator, one must consider the decay time of serum glucocorticoids and the glucocorticoid-receptor complex in the cytoplasm and nucleus of target cells. Radioimmunoassay of serum corticosterone levels indicates that there was none detectable by 2 hr after adrenalectomy. An in vivo experiment in which ['4C]cortisol was injected into a rat indicates that the halflife of the steroid-receptor complex in hepatocyte nuclei is =0.5 hr (26) , which is in agreement with values derived from in vitro studies using isolated hepatocyte nuclei (27) . It is therefore extremely interesting that the elevated POMC gene transcription rate has already reached a maximal level by 1 hr after adrenalectomy (Fig. 3) . While growth hormone gene transcription rates also change with a similar time course, although in the opposite direction, the magnitude of the response, both to adrenalectomy and to glucocorticoid treatment, is 1/10th as much [2-fold compared with 20-fold (Fig. 3)] .
The data presented illustrate the high sensitivity of POMC gene expression in the anterior pituitary to changes in glucocorticoid levels, both at the level of transcription and at the level of ACTH secretion. It is possible that the POMC gene is the site of action of the glucocorticoid-receptor complex. This is based on the short time course of derepression of transcription of the POMC gene after adrenalectomy. A direct effect of glucocorticoids on POMC transcription in AtT20D16v cells after a 1-hr treatment has also been observed (unpublished results).
It is not possible to evaluate the role of positive regulators such as CRF on induction of POMC mRNA in these experiments. However, Swanson et al. (28) have recently reported a dramatic increase in the intensity of CRF-staining cell bodies in the paraventricular nucleus, suggesting increased CRF synthesis after adrenalectomy. Increased immunostaining for CRF in connecting fibers in the median eminence (the site of CRF release) is consistent with regulation of expression of POMC in anterior pituitary cells by CRF. The increase in POMC mRNA levels in the anterior pituitary after intraventricular administration of CRF to male rats (unpublished data) also supports a role for CRF in POMC gene expression.
The rapid changes in ACTH serum levels after glucocorticoid treatment strongly suggest a separate and distinct action of glucocorticoids at the level of ACTH secretion, in agreement with results of Phillips and Tashjian (29) , who report that shortterm glucocorticoid treatment causes rapid inhibition of stimulated ACTH release in the AtT20-D16v cell line.
A rather surprising observation is the continued increase in POMC mRNA levels in the anterior pituitary through day 18 after adrenalectomy. There is no known precedent for so lengthy an increase in the level of a specific eukaryotic mRNA. By 18 days after adrenalectomy, the POMC mRNA level in the anterior lobe is only slightly below that of the neurointermediate lobe, a relatively pure population of corticotrophs (4).
Several possible explanations exist for this extended accumulation of POMC mRNA in the anterior pituitary. The corticotrophs in the anterior pituitary have been observed to increase both in size and number after adrenalectomy (30) . Expression of the POMC gene in a cell type morphologically distinct from normal corticotrophs has been observed during postnatal development (31) . Recruitment of another cell type in the anterior lobe (e.g., gonadotrophs) to begin expressing the POMC gene is therefore a possibility. Increases in size and number of cells expressing POMC in the anterior pituitary would contribute to the elevated level of POMC gene expression observed at longer times after adrenalectomy.
Within 5 days of dexamethasone treatment of adrenalectomized rats, the POMC mRNA levels in the anterior pituitary returned to control levels and did not decline any further (Fig.  1B) . The half-time of the decline of POMC mRNA during dexamethasone treatment is approximately 24 hr (Fig. 1B) . This serves as a rough estimate of the POMC mRNA half-life in the anterior pituitary. A half-life of 24 hr is considered typical for the stable class of eukaryotic mRNAs (32) .
This study shows that POMC gene expression in the anterior pituitary is inhibited by serum glucocorticoids. Other studies indicate that CRF increases POMC mRNA levels in anterior pituitary cultures and that this effect is inhibited by glucocorticoids (unpublished data). Hence, CRF may be responsible for elevating POMC mRNA levels in the anterior pituitary after adrenalectomy.
Our studies show that glucocorticoids do not play a major role in the regulation of POMC gene expression in the neurointermediate lobe. However, there is evidence for dopaminergic inhibition of POMC mRNA levels (11) and for inhibition of '--MSH secretion by y-aminobutyric acid (25) in this lobe.
Little is known about expression of POMC in the hypothalamus. Our data indicate that POMC mRNA levels are not regulated by glucocorticoids in the hypothalamus.
Regulation of POMC gene expression is best characterized in the anterior pituitary where regulation occurs at two levels of expression: transcription and secretion. The differences in regulation of POMC gene expression in the two lobes of the pituitary and hypothalamus make this system a valuable one for the study of neuropeptide gene expression.
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